Credit Suisse’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-140,056
| Closed | -$476K | – | 3453 |
|
|
2018
Q3 | $476K | Sell |
140,056
-27,204
| -16% | -$92.5K | ﹤0.01% | 2862 |
|
|
2018
Q2 | $629K | Sell |
167,260
-761
| -0.5% | -$2.86K | ﹤0.01% | 2859 |
|
|
2018
Q1 | $686K | Buy |
168,021
+43,706
| +35% | +$178K | ﹤0.01% | 2786 |
|
|
2017
Q4 | $578K | Buy |
124,315
+3,445
| +3% | +$16K | ﹤0.01% | 2870 |
|
|
2017
Q3 | $858K | Buy |
120,870
+34,576
| +40% | +$245K | ﹤0.01% | 2755 |
|
|
2017
Q2 | $624K | Sell |
86,294
-80,203
| -48% | -$580K | ﹤0.01% | 2636 |
|
|
2017
Q1 | $1.03M | Buy |
166,497
+88,411
| +113% | +$544K | ﹤0.01% | 2502 |
|
|
2016
Q4 | $457K | Buy |
78,086
+28,195
| +57% | +$165K | ﹤0.01% | 3140 |
|
|
2016
Q3 | $265K | Sell |
49,891
-79,428
| -61% | -$422K | ﹤0.01% | 3363 |
|
|
2016
Q2 | $856K | Sell |
129,319
-22,107
| -15% | -$146K | ﹤0.01% | 2779 |
|
|
2016
Q1 | $707K | Buy |
151,426
+33,875
| +29% | +$158K | ﹤0.01% | 2708 |
|
|
2015
Q4 | $594K | Buy |
117,551
+63,957
| +119% | +$323K | ﹤0.01% | 3022 |
|
|
2015
Q3 | $189K | Sell |
53,594
-53,585
| -50% | -$189K | ﹤0.01% | 3729 |
|
|
2015
Q2 | $1.07M | Buy |
107,179
+71,905
| +204% | +$717K | ﹤0.01% | 2873 |
|
|
2015
Q1 | $449K | Sell |
35,274
-58,262
| -62% | -$742K | ﹤0.01% | 3357 |
|
|
2014
Q4 | $1.32M | Buy |
93,536
+3,397
| +4% | +$48K | ﹤0.01% | 2574 |
|
|
2014
Q3 | $1.24M | Sell |
90,139
-5,575
| -6% | -$76.7K | ﹤0.01% | 2513 |
|
|
2014
Q2 | $1.47M | Sell |
95,714
-38,479
| -29% | -$592K | ﹤0.01% | 2583 |
|
|
2014
Q1 | $2.29M | Buy |
134,193
+16,560
| +14% | +$282K | ﹤0.01% | 2117 |
|
|
2013
Q4 | $1.52M | Sell |
117,633
-49,179
| -29% | -$637K | ﹤0.01% | 2540 |
|
|
2013
Q3 | $1.68M | Buy |
166,812
+121,952
| +272% | +$1.23M | ﹤0.01% | 2182 |
|
|
2013
Q2 | $335K | Buy |
+44,860
| New | +$335K | ﹤0.01% | 3176 |
|